(Q28217412)

English

Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs

scientific article

In more languages

Statements

scholarly article

0 references

Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs (English)

0 references

Jens Kågström

1

object named as

Jens Kågström

0 references

author name string

Jens Kågström

1

0 references

Eva-Lena Sjögren

2

0 references

Ann-Christin Ericson

3

0 references

language of work or name

0 references

publication date

2007

1 reference

Journal of Pharmacological and Toxicological Methods

0 references

56

0 references

2

0 references

186-93

0 references

QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Computerized evaluation of drug-induced changes in guinea-pig epicardial monophasic action potentials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: a multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Effect of carvedilol on atrioventricular conduction in the ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Case of polymorphic ventricular tachycardia in diphenhydramine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: evaluation of the potential of compounds to cause QT interval prolongation by action potential assays using guinea-pig papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Diphenhydramine overdose and Brugada sign

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

A new guinea-pig model for acute inhalation studies on combined effects of cold air and pollutants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Sino-atrial nodal cells of mammalian hearts: ionic currents and gene expression of pacemaker ionic channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Prolonged QT interval with markedly abnormal ventricular repolarization in diphenhydramine overdose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT interval prolongation in diphenhydramine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

The application of in vitro methods to safety pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

"Conventional" antihistamines slow cardiac repolarization in isolated perfused (Langendorff) feline hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Age-related differences in the direct cardiac effects of cisapride: narrower safety range in the hearts of young rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Propranolol inhibits the human ether-a-go-go-related gene potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Electrocardiographic findings in patients with diphenhydramine overdose.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.03.003

7 January 2021

Identifiers

10.1016/J.VASCN.2007.03.003

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217412&oldid=1369158611"